Dr. Joseph David Nagan, DO

Dr. Nagan practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Dr. Nagan's NPI, 1164798591, was assigned on March 29, 2012. Dr. Nagan graduated from Touro College of Osteopathic Medicine - New York in 2010. Dr. Nagan holds Texas license T2452.

Dr. Nagan's primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Dr. Nagan's primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. The medical group on file is UTMB Faculty Group Practice.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nagan practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Nagan's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Nagan is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Nagan is licensed in Texas.

Dmand AI lists acute respiratory failure, asthma, bronchitis, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pulmonary fibrosis and tobacco use among the conditions Dr. Nagan treats.

CMS data shows 505 Medicare services from Dr. Nagan across 12 procedure codes in 2024, for 263 Medicare patients. Medicare paid $39,843 for them.

CMS counts 263 Medicare patients who saw Dr. Nagan in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nagan's median patient age at 73, with 58% women.

In 2024, Dr. Nagan wrote 985 Medicare Part D claims for 173 patients. 58% of them were for generic drugs. CMS names the drug for 842 of them, across 20 drugs with 11 or more claims each, at $133,861 in total drug cost. In 2023, CMS named 744 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Nagan for performance year 2024, reported as part of a group. Dr. Nagan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dr. Nagan from 3 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $247.

Dr. Nagan graduated from Touro College of Osteopathic Medicine - New York in 2010.

Dr. Nagan is in network with 23 carriers, including Aetna, United Healthcare and Elevance. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.